Trials / Terminated
TerminatedNCT02058537
Bethanechol for Eosinophilic Esophagitis
Bethanechol for Treatment of Eosinophilic Esophagitis (EoE)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Iowa · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary goals of this study are to ease the symptoms of patients with Eosinophilic Esophagitis (EoE) and to test the effectiveness of the drug bethanechol in relieving those symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bethanechol | Due to the fact that this study has only 1 arm and all study subjects will receive the study drug in the same manner and dose, there are no other details to cover. |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-02-10
- Last updated
- 2016-04-22
- Results posted
- 2016-04-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02058537. Inclusion in this directory is not an endorsement.